A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer
- Y. H. Park
- , B. S. Kim
- , B. Y. Ryoo
- , S. H. Yang
- Seoul Veterans Hospital
Research output: Contribution to journal › Article › peer-review
78
Link opens in a new tab
Scopus
citations